Please try another search
For the six months ended 31 July 2017, Quantum Pharma PLC revenues increased 13% to £36.2M. Net income before extraordinary items increased 66% to £3M. Revenues reflect Niche segment increase from £2.3M to £5.3M, Specials segment increase of 4% to £30.9M. Net income benefited from Administrative expenses decrease of 2% to £9.7M (expense), Interest Exp-Net of Capitalized Interest decrease of 26% to £370K (expense).
Period Ending: | Jul 31, 2017 | Jan 31, 2017 | Jul 31, 2016 | Jan 31, 2016 |
---|---|---|---|---|
Total Revenue | 36.2 | 34.26 | 32.08 | 69.23 |
Gross Profit | 14.32 | 12.02 | 13.06 | 25.88 |
Operating Income | 3.57 | -11.61 | 2.06 | 7.49 |
Net Income | 2.78 | -23.73 | 0.96 | 5.6 |
Period Ending: | Jul 31, 2017 | Jan 31, 2017 | Jul 31, 2016 | Jan 31, 2016 |
---|---|---|---|---|
Total Assets | 85.65 | 90.82 | 109.52 | 107.35 |
Total Liabilities | 35.34 | 44.21 | 53.88 | 51.84 |
Total Equity | 50.31 | 46.61 | 55.63 | 55.51 |
Period Ending: | Jul 31, 2017 | Jan 31, 2017 | Jul 31, 2016 | Jan 31, 2016 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | 1.99 | 3.88 | 3.96 | 6.98 |
Cash From Investing Activities | -0.76 | -5.2 | -3.15 | -20.95 |
Cash From Financing Activities | -1.5 | 5.02 | 0.5 | 12.34 |
Net Change in Cash | -0.28 | 3.7 | 1.32 | -1.63 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review